CytoDyn CYDY
OTC CYDY
$0.25 +0.01 (+4.17%)
At close: Oct 21, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Preferred Dividend Payments (2010 - 2013)

Updated

CytoDyn's Preferred Dividend Payments was -$2,190 in FY2013 (year ended May 31, 2013), compared with -$88,743 in FY2012.

Analysis

CytoDyn (CYDY) Preferred Dividend Payments (2010 - 2013) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier fiscal years was -$88,743 in FY2012 and -$8,550 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,169.89 Bn 1,138.48 Bn 19.71 Bn -
2 Johnson & Johnson 648.35 Bn 568.21 Bn 17.30 Bn -
3 AbbVie 504.24 Bn 477.35 Bn 12.70 Bn -
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn -
5 Novartis Ag 303.28 Bn 267.27 Bn 11.24 Bn -
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn -
7 Amgen 242.76 Bn 198.16 Bn 7.24 Bn -
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn -
9 Pfizer 172.99 Bn 119.64 Bn 10.94 Bn -
10 CytoDyn 330.07 Mn 281.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2013 -790.00
Aug 31, 2012 -1,400.00
May 31, 2012 -21,450.00
Feb 29, 2012 -67,293.00
Feb 28, 2011 -5,800.00
Nov 30, 2010 -2,750.00
API Access

CytoDyn Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=CYDY&period=max&api_key=YOUR_API_KEY